Development of a mouse model of mammary gland versus uterus tissue selectivity using estrogen- and progesterone-regulated gene markers

Journal of Steroid Biochemistry and Molecular Biology

Volumn 101, Issue 1, 2006, Pages 11-21

  Crabtree, Judy S ^a   Zhang, Xiaochun ^a   Peano, Bryan J ^a   Zhang, Zhiming ^a   Winneker, Richard C ^a   Harris, Heather A ^a  

^a PFIZER INC   (United States)

Author keywords

Estrogen; Expression profiling; Mammary gland; Mouse model; Progesterone

Indexed keywords

2 (3 FLUORO 4 HYDROXYPHENYL) 7 VINYL 5 BENZOXAZOLOL; BETA DEFENSIN 1; BIOLOGICAL MARKER; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 105; HORMONE RECEPTOR STIMULATING AGENT; INDOLEAMINE 2,3 DIOXYGENASE; KAZAL TYPE 3 PROTEIN; LIGAND; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; PROGESTERONE; PROGESTERONE RECEPTOR; PROPYLPYRAZOLE TRIOL; SERINE PROTEINASE INHIBITOR; TANAPROGET; UNCLASSIFIED DRUG; WAY 202196;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC MODEL; GENETIC REGULATION; HISTOLOGY; HORMONAL REGULATION; IN VIVO STUDY; MAMMARY GLAND; MARKER GENE; MOUSE; NONHUMAN; OVARIECTOMY; QUANTITATIVE ASSAY; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; UPREGULATION; UTERUS;

ANIMALS; BASE SEQUENCE; BENZOXAZINES; DNA PRIMERS; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKERS; MAMMARY GLANDS, ANIMAL; MEDROXYPROGESTERONE 17-ACETATE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; NAPHTHOLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXAZOLES; PROGESTERONE; PYRAZOLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIONES; UTERUS;

EID: 33748084024     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.06.017     Document Type: Article

References (22)

1. Silberstein G.B. Postnatal mammary gland morphogenesis. Microsc. Res. Tech. 52 (2001) 155-162
2. Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H., and Chambon P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9 5 (1990) 1602-1614
3. Conneely O.M., Mulac-Jericevic B., DeMayo F., Lydon J.P., and O'Malley B.W. Reproductive functions of progesterone receptors. Recent Prog. Hormone Res. 57 (2002) 339-355
4. Mulac-Jericevic B., Lydon J.P., DeMayo F.J., and Conneely O.M. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl. Acad. Sci. U.S.A. 100 17 (2003) 9744-9749
5. Green S., Kumar V., Krust A., Walter P., and Chambon P. Structural and functional domains of the estrogen receptor. Cold Spring Harb. Symp. Quant. Biol. 51 Pt 2 (1986) 751-758
6. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., and Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93 12 (1996) 5925-5930
7. Hewitt S.C., and Korach K.S. Oestrogen receptor knockout mice: roles for oestrogen receptors alpha and beta in reproductive tissues. Reproduction 125 2 (2003) 143-149
8. Fensome A., Bender R., Chopra R., Cohen J., Collins M.A., Hudak V., Malakian K., Lockhead S., Olland A., Svenson K., Terefenko E.A., Unwalla R.J., Wilhelm J.M., Wolfrom S., Zhu Y., Zhang Z., Zhang P., Winneker R.C., and Wrobel J. Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget. J. Med. Chem. 48 16 (2005) 5092-5095
9. Zhang Z., Olland A.M., Zhu Y., Cohen J., Berrodin T., Chippari S., Appavu C., Li S., Wilhem J., Chopra R., Fensome A., Zhang P., Wrobel J., Unwalla R.J., Lyttle C.R., and Winneker R.C. Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget. J. Biol. Chem. 280 31 (2005) 28468-28475
10. Harris H.A., Katzenellenbogen J.A., and Katzenellenbogen B.S. Characterization of the biological roles of the estrogen receptors, ER alpha and ER beta, in estrogen target tissues in vivo through the use of an ER alpha-selective ligand. Endocrinology 143 11 (2002) 4172-4177
11. Harris H.A., Albert L.M., Leathurby Y., Malamas M.S., Mewshaw R.E., Miller C.P., Kharode Y.P., Marzolf J., Komm B.S., Winneker R.C., Frail D.E., Henderson R.A., Zhu Y., and Keith Jr. J.C. Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 144 10 (2003) 4241-4249
12. Mewshaw R.E., Edsall R.J., Yang C.J., Manas E.S., Xu Z.B., Henderson R.A., Keith J.C., and Harris H.A. ER beta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ER beta selectivity. J. Med. Chem. 48 12 (2005) 3953-3979
13. Malamas M.S., Manas E.S., McDevitt R.E., Gunawan I., Xu Z.B., Collini M.D., Miller C.P., Dinh T., Henderson R.A., Keith Jr. J.C., and Harris H.A. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands. J. Med. Chem. 47 21 (2004) 5021-5040
14. Rasmussen S., Young L., and Smith G. Preparing mammary gland whole mounts from mice. In: Ash B. (Ed). Methods in Mammary Gland Biology and Cancer Research (2000), Kluwer Academic/Plenum Publishers, New York 75-85
15. Tunzi C.R., Harper P.A., Bar-Oz B., Valore E.V., Semple J.L., Watson-MacDonell J., Ganz T., and Ito S. Beta-defensin expression in human mammary gland epithelia. Pediatr. Res. 48 1 (2000) 30-35
16. Jia H.P., Starner T., Ackermann M., Kirby P., Tack B.F., and McCray Jr. P.B. Abundant human beta-defensin-1 expression in milk and mammary gland epithelium. J. Pediatr. 138 1 (2001) 109-112
17. Muller A.J., DuHadaway J.B., Donover P.S., Sutanto-Ward E., and Prendergast G.C. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat. Med. 11 3 (2005) 312-319
18. Neuschwander-Tetri B.A., Fimmel C.J., Kladney R.D., Wells L.D., and Talkad V. Differential expression of the trypsin inhibitor SPINK3 mRNA and the mouse ortholog of secretory granule protein ZG-16p mRNA in the mouse pancreas after repetitive injury. Pancreas 28 4 (2004) e104-e111
19. Travers M.T., Gow I.F., Barber M.C., Thomson J., and Shennan D.B. Indoleamine 2,3-dioxygenase activity and l-tryptophan transport in human breast cancer cells. Biochim. Biophys. Acta 1661 1 (2004) 106-112
20. Tibbetts T.A., Conneely O.M., and O'Malley B.W. Progesterone via its receptor antagonizes the pro-inflammatory activity of estrogen in the mouse uterus. Biol. Reprod. 60 5 (1999) 1158-1165
21. Moore D.J., Murdock P.R., Watson J.M., Faull R.L., Waldvogel H.J., Szekeres P.G., Wilson S., Freeman K.B., and Emson P.C. GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function. Brain Res. Mol. Brain Res. 118 1-2 (2003) 10-23
22. Ismail P.M., DeMayo F.J., Amato P., and Lydon J.P. Progesterone induction of calcitonin expression in the murine mammary gland. J. Endocrinol. 180 2 (2004) 287-295